openPR Logo
Press release

Drug Pricing in the US

11-08-2017 08:58 AM CET | Health & Medicine

Press release from: ReportsWorldwide

Boston, MA

ReportsWorldwide has announced the addition of a new report title Drug Pricing in the US to its growing collection of premium market research reports.

Drug prices in the US have been the subject of intense debate over the past 2–3 years, following a surge in spending on prescription medicines and steep price increases in some categories. Public support for government action to curb prices is widespread.

President Donald Trump has vowed to intervene, and the federal government is expected to unveil pricing reform proposals during the second half of 2017. In the meantime, state legislatures are debating a slew of bills designed to address prescription drug prices and curb pharmaceutical spending, while in the private sector, other stakeholders are keen to exert more control over a pricing agenda that is currently dominated by manufacturers and pharmacy benefit managers

For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/drug-pricing-in-the-us

Below are the key topics covered in this Report :

EXECUTIVE SUMMARY

• Paying the price for unrivaled access to prescription drugs
• Rebating has fueled a period of dramatic list price inflation
• Winners and losers under the current system
• Prospects for change

THE PRICING DEBATE RESURFACES

• A familiar problem that never went away
• Bibliography

PUBLIC SECTOR PRICES

• Not so free in practice
• Labyrinthine rules limit public purchasing and reimbursement prices
• The public sector drugs bill is still rising rapidly
• Bibliography

PRIVATE SECTOR PRICES

• Where market forces truly do run free
• PBMs – the pharmaceutical industry's main adversary
• PBM pressure has driven a rebating arms race
• Bibliography

THE REBATING BONANZA

• A solution, or part of the problem?
• List prices versus net prices: the gap becomes a gulf
• List price hikes have been used to create headroom for rebates
• Rebates soar, but net prices still comfortably outpace inflation
• Resetting the drug pricing debate
• Winners and losers under the current system
• Bibliography

DRUG PRICE REFORM PROSPECTS

• How might the drug pricing debate play out?
• Public support for pricing intervention is strong
• Public program prices and spending top the federal agenda
• Federal inaction prompts states to begin legislating on prices
• Market dynamics in the private sector begin to shift
• Seeking “value for money”
• Endgame scenarios
• Bibliography

APPENDIX

• About the author
• Scope
• Methodology

To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=41340

About ReportsWorldwide.com

ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston, MA 02110
US
Phone +1 (617) 398-1947
abigail@reportsworldwide.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Pricing in the US here

News-ID: 806663 • Views: 285

More Releases from ReportsWorldwide

World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of
UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply …
Boston, MA ReportsWorldwide has announced the addition of a new report title UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply Chain in India – 2017 to its growing collection of premium market research reports. UDAY scheme was touted as the next paladin to bail out the struggling Discoms, in order to turn them green in a time horizon of 3-4 years from 2015/16. Though was optional for the

All 5 Releases


More Releases for Public

International Conference on Public Health
We delightfully welcome you to the ''International Conference on Public Health'' is going to be held on August 16-17, 2021 at Berlin, Germany. This conference will focus on the theme "Challenging the Sustainability of Future Health Care and the Quality of Life".It will provide an excellent international forum for sharing knowledge and experience. The Conference focusing mainly on the secessions mental health, mental disorder, non-communicable diseases, public health
Epidemiology and Public Health
Opportunity to attend/speak at Epidemiology 2019 on February 27-28, 2019 at Prague, Czech Republic with the theme of Emerging Technologies, Applications and Health transitions in Epidemiology and Public Health. https://epidemiology.euroscicon.com/ Whatsapp: 13024004945 Euroscicon Milevská 7, 140 63 Praha 4, Czechia Katherine Gracia
Centigrade releases XamlBoard Public Beta
Press release from: Centigrade GmbH (openPR) - Having already showcased a preliminary demo of the XamlBoard product on the Developer Week exhibition, the public beta version of Centigrade´s XamlBoard is now available for download: centigrade.de/en/products/xaml-board XamlBoard 0.9.79 does not only represent the first publicly available version of XamlBoard – moreover, Centigrade expands its yet Java-oriented product portfolio by its first .NET-aimed product. In this context, XamlBoard represents a first-of-its-kind tool being geared
Public Sector ICT Procurement
European Seminar, 4th – 5th March 2013, Berlin, Germany The European Academy for Taxes, Economics & Law invites representatives from all public institutions on national, regional and local level planning ICT projects and the procurement of ICT solutions, as well as providers of ICT solutions for the public sector, lawyers and consultants in the field of public procurement to the European Seminar “Public Sector ICT Procurement” to take place in Berlin
ENCITE Final Public Workshop
The European Network for Cell Imaging and Tracking Expertise invites you to the final public event. Monday, 5 November 2012, 8:00 – 18:00 Leiden University Medical Center, Leiden/NL Programme available at: www.encite.org No registration fee required! For pre-registration, please send an email to: All involved scientists in ENCITE are very pleased to announce that the end of the highly successful ENCITE project will be marked by a closing event presenting new technologies and methods
02-27-2012 | Health & Medicine
PMR Ltd
Most non-public hospitals in Poland oriented towards public funding
The vast majority of non-public hospitals in Poland provide services under contracts with the National Health Fund (NFZ). The number of Poles who can afford to pay for costly hospital procedures out of their own pockets remains small, whereas NFZ contracts guarantee a certain level of revenues and patient numbers. That is why even those private hospitals whose original focus was exclusively on commercial patients (e.g. Medicover) decide to enter